← Latest Filings
J
Jarrett Jennifer
Director, President and CEO
Open-market buys
1
$253K total
Open-market sells
2
$467K total
Tracking since
Dec 2025
Activity timeline
Open-market buy — $253K
Damora Therapeutics, Inc. · Sep 25, 2026
Open-market sale — $221K
Arcus Biosciences, Inc. · Dec 17, 2025
Open-market trades from the last two years.
Holdings as last reported
1,500,000 Stock Option (right to buy) in DMRA
Held directly · as of 2026-03-30
512,500 Ordinary Shares in DMRA
Held directly · as of 2026-09-25
Companies touched
Damora Therapeutics, Inc.
CIK 0001800315
Syndax Pharmaceuticals Inc
CIK 0001395937
